121 related articles for article (PubMed ID: 15341441)
21. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
[TBL] [Abstract][Full Text] [Related]
22. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
Fukuda M; Nakatsuka T; Kusama K; Sakashita H
J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
[No Abstract] [Full Text] [Related]
23. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka.
Chiba I; Muthumala M; Yamazaki Y; Uz Zaman A; Iizuka T; Amemiya A; Shibata T; Kashiwazaki H; Sugiura C; Fukuda H
Int J Cancer; 1998 Sep; 77(6):839-42. PubMed ID: 9714051
[TBL] [Abstract][Full Text] [Related]
25. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users.
Lazarus P; Garewal HS; Sciubba J; Zwiebel N; Calcagnotto A; Fair A; Schaefer S; Richie JP
Int J Cancer; 1995 Feb; 60(4):458-63. PubMed ID: 7829258
[TBL] [Abstract][Full Text] [Related]
26. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
Yamazaki Y; Chiba I; Hirai A; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Iizuka T; Kohgo T; Fukuda H
Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
[TBL] [Abstract][Full Text] [Related]
27. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India.
Kannan K; Munirajan AK; Krishnamurthy J; Bhuvarahamurthy V; Mohanprasad BK; Panishankar KH; Tsuchida N; Shanmugam G
Int J Oncol; 1999 Dec; 15(6):1133-6. PubMed ID: 10568819
[TBL] [Abstract][Full Text] [Related]
28. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
30. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
Sakai E; Rikimaru K; Ueda M; Matsumoto Y; Ishii N; Enomoto S; Yamamoto H; Tsuchida N
Int J Cancer; 1992 Dec; 52(6):867-72. PubMed ID: 1459726
[TBL] [Abstract][Full Text] [Related]
31. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia.
Michailidou E; Tzimagiorgis G; Chatzopoulou F; Vahtsevanos K; Antoniadis K; Kouidou S; Markopoulos A; Antoniades D
Cancer Epidemiol; 2016 Aug; 43():112-8. PubMed ID: 27263493
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
[TBL] [Abstract][Full Text] [Related]
33. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
34. p53 expression and p53 gene mutation in oral cancer and dysplasia.
Rowley H; Sherrington P; Helliwell TR; Kinsella A; Jones AS
Otolaryngol Head Neck Surg; 1998 Jan; 118(1):115-23. PubMed ID: 9450841
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
[TBL] [Abstract][Full Text] [Related]
36. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
Chen Q; Fu J; Yang G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):337-40. PubMed ID: 9592286
[TBL] [Abstract][Full Text] [Related]
37. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.
Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW
J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733
[TBL] [Abstract][Full Text] [Related]
38. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
40. P53-mutation in smears of oral squamous cell carcinoma.
Friedrich RE; Giese M; Riethdorf S; Loning T
Anticancer Res; 2000; 20(6D):4927-30. PubMed ID: 11326641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]